Market Tracker

03/27 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

6.05
Delayed Data
As of 3:59pm ET
 +0.05 / +0.83%
Today’s Change
3.20
Today|||52-Week Range
23.62
+53.16%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close6.00
Today’s open5.95
Day’s range5.85 - 6.23
Volume1,507,872
Average volume (3 months)1,848,131
Market cap$266.1M
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+29.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
OCULOcular Therapeutix I...+0.09+0.97%
NERVMinerva Neuroscience...+0.85+11.18%
ZGNXZogenix Inc+0.45+4.31%
ZYNEZynerba Pharmaceutic...+1.51+7.68%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts